Champions Oncology (STU:2I3) Total Assets : €23.17 Mil (As of Oct. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Champions Oncology Total Assets?

Champions Oncology's Total Assets for the quarter that ended in Oct. 2024 was €23.17 Mil.

Warning Sign:

If a company builds assets at 24% a year, faster than its revenue growth rate of 14.2% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Champions Oncology's average Total Assets Growth Rate was -12.00% per year. During the past 3 years, the average Total Assets Growth Rate was 0.90% per year. During the past 5 years, the average Total Assets Growth Rate was 24.00% per year. During the past 10 years, the average Total Assets Growth Rate was 30.40% per year.

During the past 13 years, Champions Oncology's highest 3-Year average Total Assets Growth Rate was 96.20%. The lowest was -29.30%. And the median was 16.00%.

Total Assets is connected with ROA %. Champions Oncology's annualized ROA % for the quarter that ended in Oct. 2024 was 11.58%. Total Assets is also linked to Revenue through Asset Turnover. Champions Oncology's Asset Turnover for the quarter that ended in Oct. 2024 was 0.54.

Champions Oncology Total Assets Historical Data

The historical data trend for Champions Oncology's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Champions Oncology Total Assets Chart

Champions Oncology Annual Data

Trend

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Apr24

Total Assets

Get a 7-Day Free Trial

19.09

23.07

32.76

31.29

24.36

Champions Oncology Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
Total Assets	Get a 7-Day Free Trial															26.79	24.59	24.36	22.99	23.17

Champions Oncology Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Champions Oncology's Total Assets for the fiscal year that ended in Apr. 2024 is calculated as

Total Assets	=	Total Equity (A: Apr. 2024 )	+	Total Liabilities (A: Apr. 2024 )
	=	-1.774	+	26.129
	=	24.36

Champions Oncology's Total Assets for the quarter that ended in Oct. 2024 is calculated as

Total Assets	=	Total Equity (Q: Oct. 2024 )	+	Total Liabilities (Q: Oct. 2024 )
	=	0.625	+	22.545
	=	23.17

Champions Oncology (STU:2I3) Total Assets Explanation

Total Assets is connected with ROA %.

Champions Oncology's annualized ROA % for the quarter that ended in Oct. 2024 is

ROA %	=	Net Income (Q: Oct. 2024 )	/	( (Total Assets (Q: Jul. 2024 )	+	Total Assets (Q: Oct. 2024 ))	/ count )
	=	2.672	/	( (22.988	+	23.17)	/ 2 )
	=	2.672	/	23.079
	=	11.58 %

Note: The Net Income data used here is four times the quarterly (Oct. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Champions Oncology's Asset Turnover for the quarter that ended in Oct. 2024 is

	Asset Turnover
=	Revenue (Q: Oct. 2024 )	/	( (Total Assets (Q: Jul. 2024 )	+	Total Assets (Q: Oct. 2024 ))	/ count )
=	12.383	/	( (22.988	+	23.17)	/ 2 )
=	12.383	/	23.079
=	0.54

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Champions Oncology Total Assets Related Terms

Thank you for viewing the detailed overview of Champions Oncology's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Champions Oncology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Champions Oncology Inc (STU:2I3) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

CSBR:USA

Address

One University Plaza, Suite 307, Hackensack, NJ, USA, 07601

Website

https://www.championsoncology.com

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

Champions Oncology Headlines

No Headlines